Clinical Trial Update: Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Nasonex (mometasone furoate) nasal spray to placebo in participants with seasonal allergic rhinitis and concurrent asthma; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal, Asthma | Phase 4 | Status: COMPLETED | Results posted: 2019-07-18